BioBrit

Castle Biosciences develops, manufactures and commercializes diagnostic and prognostic molecular tests in areas such as dermatology (melanoma), uveal melanoma, gastroenterology (Barrett's esophagus) and mental health.

BiotechDigital HealthHealthtechMedical DevicesFriendswood, US

Derek Maetzold(Executive Officer, Director)Derek J. Maetzold(Founder, President & Chief Executive Officer)Frank Stokes(Chief Financial Officer)Kristen Oelschlager(Chief Operating Officer)Toby Juvenal(Chief Commercial Officer)Hillary Caruso(Chief of Staff)

Co-investorsIllumina VenturesMountain Group Capital

Compass Therapeutics develops antibody-based therapies targeting the tumor microenvironment to treat cancer.

BiotechHealthtechCambridge, US

Co-investorsF-Prime Capital PartnersForesite CapitalOrbiMedvenBio PartnersVivo Capital

Tyra is developing oral dabogratinib, a small-molecule therapy being evaluated in clinical studies for skeletal dysplasia and urologic cancers.

BiotechHealthtechCarlsbad, US

Todd Harris, Ph.D.(Executive Officer, Director)Hiroomi Tada, M.D., Ph.D.(Executive Officer)Daniel Bensen(Executive Officer)Alan Fuhrman(Executive Officer)

BoardRobert More(Director)Nina Kjellson(Director)in

Co-investorsAlta PartnersNextech InvestCanaan Partners

BiotechSan Diego, US

Douglas J. Jolly(Founder)inCarlos E. Ibanez(Executive Officer)Robert Anthony Williamson(Director)Troy Wilson(Director)Michael Martin(Director)Nicholas A. Boyle, Ph.D.(Executive Officer, Director)

BiotechHealthtechMedical Devices

Co-investorsDag Ventures

Co-investorsSolas BioVentures

Alta Partners is a venture capital firm that invests in and helps build healthcare and biotechnology companies, backing entrepreneurs developing therapeutics and medical innovations.

BiotechHealthtech

BiotechSan Diego, US

Francois Ferre(Director)Jorge Garces(Executive Officer)Greg Hamilton(Executive Officer, Director)J. Matthew Mackowski(Director)Carin Sandvik(Executive Officer)James Glavin(Director)

Co-investorsVivo Capital

BiotechLa Jolla, US

Quyen Nguyen(Executive Officer, Director)Kaveri Parker(Executive Officer)Brett Berman(Executive Officer, Director)James Schmidt(Executive Officer)

BoardKim Kamdar(Director)Dan Bradbury(Director)in

BiotechPompano Beach, US

Jean Kim(Director)Paul Hawkins(Executive Officer, Director)Terry Vance(Director)Matthew Pauls(Director)Patricio Sepulveda(Executive Officer, Director)in

BoardDaniel Bradbury(Director)in

Co-investorsKeiretsu ForumSofinnova Ventures

Aspen Biosciences develops software tools and applications for drug discovery companies to plan, manage, and execute research programs, including applications for managing the discovery process and integrating target and pathway data.

BiotechHealthtechSaaSSan Diego, US

Attralus develops pan-amyloid removal (PAR) therapeutics — biologics and imaging agents designed to bind and remove toxic amyloid — to treat patients with systemic amyloidosis across all disease types and stages.

BiotechHealthtechSouth San Francisco, US

Jonathan Wall(Executive Officer)Spencer Guthrie(Executive Officer)Mark Timney(Executive Officer, Director)Benson Fong(Executive Officer)Rahul Kakkar(Director)Greg Bell(Executive Officer)

Co-investorsAlpha Wave GlobalvenBio PartnersvenBio Global Strategic

Biolinq develops a non-invasive glucose sensor that uses light to display glucose levels in real time, while also tracking activity and sleep to provide personalized health insights via a mobile app.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Jared Tangney(Executive Officer, Director, Promoter)inRichard Yang(Executive Officer, Director)Edward Kliphuis(Director)

BoardDaniel Bradbury(Director)inLana Ghanem(Director)

Co-investorsAlpha Wave GlobalBeyond CapitalJDRF T1D FundHikma Ventures

BiotechSan Diego, US

Tony Broad(Executive Officer)Francois Ferre(Director)Nick Ecos(Executive Officer, Director)Joseph Markee(Executive Officer, Director)

BioRock Ventures is a seed-stage venture capital fund that invests in private life science startups developing novel FDA-regulated therapeutic drugs across all disease areas and modalities.

Biotech

Co-investorsAtacama Ventures

BiotechMarlborough, US

Lauren Jennings(Executive Officer)Warren Clark(Executive Officer)Stephen Sagon(Executive Officer, Director)Anjie Roldan(Executive Officer)Warren R. Clark III(Executive Officer)Charles Larson(Director)

Co-investorsSV Health Investors

Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease.

AI & Machine LearningBiotechDeep Tech

Co-investorsDCVC (Data Collective)Tenmile

BiotechSan Diego, US

Ross Bundy(Executive Officer, Director)Kiana Aran(Director)Michael Heltzen(Director)

BoardGeorge Bonaros(Director)Paul Grint(Director)Toby Richardson(Director)

Co-investorsSerra Ventures

DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing.

BiotechHealthtechMedical DevicesHighland, US

Mary Gardner(Chief Executive Officer & Founder)inSameer B. Shah(Chief Scientist)Steven Yoelin(Chief Medical Strategist)Dimas Jimenez(Chief Financial Advisor)

BoardDaniel Bradbury(Director)

EcoR1 Capital is an investment firm focused on the biotechnology and life sciences sector.

Biotech

Co-investorsSofinnova Ventures

Encoded develops gene therapies for neurological disorders through an integrated platform approach.

Biotech

Stephanie Tagliatela(Founder)in

Co-investorsARCH Venture PartnersGV (Google Ventures)Illumina VenturesMenlo VenturesSoftBank Vision FundVenrock

Co-investorsCota CapitalDecheng Capital

Non-invasive diagnostic tools for detecting and managing chronic diseases such as diabetes.

San Diego, US

John D Gerace(Executive Officer, Director)Craig Misrach(Director)

BoardDan Bradbury(Director)inAndy Sassine(Director)Lynn-Ann Gries(Director)James E. Pinkin(Director)

Co-investorsBootstrap Venture Partners

Genalyte is developing Merlin, an automated diagnostic device that processes blood samples on-site and returns lab results within minutes while the patient waits.

Digital HealthHardwareMedical Devices

Co-investorsClaremont Creek VenturesFusionX VenturesIPD CapitalTEL Venture Capital, Inc.

Hemostemix is a clinical-stage regenerative medicine company developing ACP-01, an investigational autologous (patient-derived) stem cell therapy for vascular and ischemic conditions such as critical limb ischemia, peripheral arterial disease, ischemic cardiomyopathy, and heart failure.

BiotechHealthtechLongevityMedical DevicesBlackfalds

Roger Bergersen(Founder (of predecessor TheraVitae Inc.))Ina Sarel(VP, Research and Development)Kyle Makofka(Chief Restructuring Officer)David Berman(Chief Financial Officer)Angus Jenkins(Director)Don Friesen(Director)

In The Bowl Animal Health (ITBAH) develops and commercializes antiparasitics and therapeutics for pets by incorporating the drug directly into the pet's daily food to improve compliance and convenience.

BiotechConsumerFoodTechHealthtechNashville, US

Randolph Legg(Chief Executive Officer)Scott Holmstrom, Ph.D.(Chief Scientific Officer)Eric Graves(Director)Jay Ferguson(Executive Officer)Robin Readnour(Director)Diane Hirakawa(Director)

Co-investorsMountain Group Capital

HealthtechSan Diego, US

Kian Saneii(Executive Officer, Director)Richard Della Penna(Executive Officer)Gary Gilmore(Executive Officer)John Carrington(Director)Jaye Connolly(Executive Officer)Zach Hornby(Director)

Intercept Pharmaceuticals is a biopharmaceutical company developing medicines for rare and serious liver diseases, with research centered on Farnesoid X Receptor (FXR) biology for conditions such as severe alcohol-associated hepatitis.

BiotechMedical Devices

Co-investorsAisling CapitalRidgeback Capital

San Diego, US

Samir Damani(Executive Officer, Director)Arthur Roke(Executive Officer)Pratik Patel(Executive Officer)

BoardJean Balgrosky(Executive Officer, Director)inGarrett Vygantas(Director)Jacqueline Kosecoff(Director)

Co-investorsBootstrap Venture Partners

MedExcel Capital (MEC) is a venture capital firm investing in precision health and life sciences companies at company-creation, seed, Series A, and Series B stages.

AI & Machine LearningBiotechHealthtech

Minutia develops insulin-producing cell transplants that can be monitored in vivo over time, aimed at improving cell replacement therapy for diabetes.

BiotechDeep TechDigital Health

A biopharmaceutical company developing medicines across oncology, hematology, neuroscience, immunology, and cardiovascular disease areas.

BiotechHealthtech

Co-investorsAvoro Capital Advisors

Telemynd (Mynd Analytics) provides personalized online therapy and psychiatric care, including individual, couples, and child/adolescent therapy plus medication management, delivered by licensed providers nationwide and accepted through insurance.

Digital HealthHealthtechMental HealthAliso Viejo, US

Paul Buck(Executive Officer)George Carpenter(Executive Officer)Walter Schindler(Director)Richard Turner(Director)Thomas Tierney(Director)

BoardZachary McAdoo(Director)

Co-investorsFusionX Ventures

Dowds is a UK-based engineering company providing integrated technical solutions and design-led project delivery for complex built environments, with particular expertise in healthcare infrastructure, mechanical, electrical, and building systems integration.

Construction TechHealthtechUK, GB

Co-investorsAscension VenturesSignet Healthcare Partners

Ovid develops targeted small molecule therapies aimed at reducing seizures with improved safety and tolerability for people affected by epilepsies and other neurological brain conditions.

BiotechHealthtech

Co-investorsSanofi Ventures

Persephone Biosciences develops a synbiotic (probiotic and prebiotic combination) supplement for infants designed to replenish key beneficial gut bacteria.

BiotechFemTechHealthtechSan Diego, US

Stephanie Culler(Founder/CEO)inStephen Van Dien(Founder/CTO)in

Co-investorsFifty YearsFirst Bight VenturesHemi Ventures, LlcOcampo CapitalY CombinatorDCVC (Data Collective)+1 more

Primmune Therapeutics develops PRTX007, an orally administered, systemically active TLR7 agonist that activates interferon-associated innate immune pathways for use in cancer immunotherapy.

BiotechHealthtechCarlsbad, US

Co-investorsBioRock VenturesSamsara BioCapitalPolaris Partners

ProciseDx develops diagnostic technology, including a point-of-care testing platform, drawing on expertise in central lab instrumentation and point-of-care devices.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Larry Mimms(Executive Officer, Director)Magda Marquet(Director)Martin Hendrix(Director)Larry Abensur(Director)Peter Westlake(Executive Officer, Director)

PTM Therapeutics is a biotech company developing therapeutic antibodies that target Post Translational Modifications (PTMs) to create more disease-specific targets.

Biotech

Co-investorsBioRock Ventures

RayBalance develops a proprietary, non-reformulation platform that treats the subcutaneous injection administration site as a delivery-performance variable to improve absorption predictability without altering a partner's drug product.

BiotechDeep TechMedical DevicesSan Diego, US

Red Tree is a life science venture capital firm using a West Coast-focused, early-stage investment strategy.

Biotech

Renova Therapeutics develops investigational gene therapies intended as single-dose, long-lasting treatments for common chronic diseases, with an initial focus on congestive heart failure and type 2 diabetes.

BiotechHealthtechCarlsbad, US

Kirk Hammond(Director)Shawn Swaney(Executive Officer)

BoardRoy Cosan(Director)Pierre Lecocq(Director)Vijay Mahant(Director)Michael Torres(Director)

RNAV8 Bio develops a toolkit for engineering mRNA therapeutics, optimizing non-coding sequences to improve expression and efficacy of mRNA-based treatments.

AI & Machine LearningBiotechLaguna Niguel, US

Devan ShahMichelle Lynn Hall

Co-investorsElmehøj VenturesPortal InnovationsService Provider Capital

Samsara Capital is an investment firm that backs the development of therapeutics for patients.

Biotech

Co-investorsModi Ventures

San Diego, US

Co-investorsUlu Ventures

Sensulin is a preclinical biopharmaceutical company developing glucose-responsive insulin therapies for type 1 and type 2 diabetes that aim to reduce hypoglycemia risk and daily injection requirements.

BiotechMedical Devices

Dan Bradbury(Executive Chairman and Co-Founder)inMike Moradi(CEO)in

BoardAnanth AnnapragadainChristopher Rhodesin

Co-investorsCortado Ventures

Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age.

ConsumerLongevityWellness & Fitness

Co-investors1315 Capital

Co-investorsMission BiocapitalNext Frontier Capital

Stuart Therapeutics is a clinical-stage pharmaceutical company developing synthetic collagen mimetic peptides (its PolyCol platform) designed to bind and repair damaged helical collagen in the extracellular matrix.

BiotechDeep TechHealthtech

Robert O. Baratta(Co-founder)Shawn DeLorey(Operations & Corporate Development (inventor of PolyCol))

HealthtechSan Diego, US

Nicholas L. Teti, Jr.(Executive Officer, Director)Joseph A. Newcomb(Executive Officer)Stewart M. Brown(Executive Officer)

BoardClarke B. Futch(Director)Paul J. Hadden(Director)Todd C. Davis(Director)

Co-investorsEssex Woodlands Healthcare Partners

Co-investorsAisling CapitalAvoro Capital AdvisorsDelos CapitalEcoR1 Capital